1. Home
  2. AXG vs FTRE Comparison

AXG vs FTRE Comparison

Compare AXG & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AXG

Solowin Holdings Class A Ordinary Share

N/A

Current Price

$3.55

Market Cap

712.4M

Sector

Finance

ML Signal

N/A

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$13.31

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXG
FTRE
Founded
2021
1996
Country
Hong Kong
United States
Employees
33
N/A
Industry
Investment Bankers/Brokers/Service
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
712.4M
829.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
AXG
FTRE
Price
$3.55
$13.31
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$14.06
AVG Volume (30 Days)
115.3K
1.5M
Earning Date
01-09-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
$28.53
N/A
Revenue Next Year
$54.60
$3.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.00
52 Week Low
$2.69
$3.97
52 Week High
$4.75
$18.67

Technical Indicators

Market Signals
Indicator
AXG
FTRE
Relative Strength Index (RSI) 41.96 55.18
Support Level $3.49 $8.85
Resistance Level $3.94 $18.26
Average True Range (ATR) 0.11 0.78
MACD -0.02 -0.23
Stochastic Oscillator 10.34 9.69

Price Performance

Historical Comparison
AXG
FTRE

About AXG Solowin Holdings Class A Ordinary Share

Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: